Asahi Kasei Medical America, Inc. - - BioPharm International

ADVERTISEMENT

Asahi Kasei Medical America, Inc.

BioPharm International
Volume 19, Issue 12

Company Description



Asahi Kasei Medical America,Inc., develops Planova filters, which are designed specifically for virus removal. Used in commercial processes since 1989, Planova filters significantly enhance safety in biopharmaceuticals and plasma-derived therapeutics. Asahi Kasei Medical America supplies Planova virus removal filters to biopharmaceutical companies worldwide. In particular, the USA Long Island branch of Asahi Kasei Medical America is responsible for the support of Planova activities in biopharmaceutical companies in USA and Canada.

Biopharmaceutical Techniques Supported

  • Virus removal filtration
  • Virus filter integrity testing

Markets Served
  • Biopharmaceutical production
  • Plasma-derived therapeutics

Products and Services

  • Planova Virus Removal Filters
  • AGP-HA Gold Particle Integrity Test Solutions
  • Planova Leak Tester (PLT)
  • Development Assistance: Planova representatives can speed your development of this crucial step with a free evaluation, laboratory visit, or assistance with your virus validations.
  • Scale Up Assistance: We can consult during process scale-up about filter sizing, skid design, and process integration.
  • Training: Multiple training seminars are held throughout the year for small or large groups, with hands-on Planova filtration training and gold particle test performance.
  • Workshops: Yearly customer-driven workshops are held for the real-time exchange of Planova experiences, techniques, improvements and strategies.

Facilities

Planova Manufacturing: Planova Manufacturing Plant, Nobeoka, Japan

Japan Corporate Offices: Asahi Kasei Medical Co., LTD, Tokyo, Japan

USA Main Office: Westbury, Long Island, NY



Satellite Offices: San Diego, CA and Windham, NH

ASAHI KASEI MEDICAL AMERICA, INC.
Long Island Branch,
Planova Division
1600 Stewart Avenue,
Suite 602
Westbury, NY 11590

TELEPHONE
516.620.3130
877.PLANOVA

FAX
516.620.3135

EMAIL

WEB ADDRESS
http://www.ak-america.com/

EMPLOYEES
5

FOUNDED
1994

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Novartis Reports Positive Results for Secukinumab in Ankylosing Spondylitis Trials
October 23, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Author Guidelines
Source: BioPharm International,
Click here